Top Markets
Coin of the day
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336
株式のランク #3340
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
株価
$6.23
時価総額
$5.58B
変化(1日)
-1.10%
変化(1年)
25.53%
CN
取引 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

カテゴリー

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd(688336)の株価履歴
終値の最高値: $6.78 (2026-08-01)

終値の最安値: $4.81 (2020-07-01)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd の株価履歴(2020 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 5.67%
2025 188.76%
2024 -5.91%
2023 62.34%
2022 -30.84%
2021 -25.95%
2020 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$772.27 7.33%
CH